US gastrointestinal (GI) and rare diseases specialist Ironwood Pharmaceuticals (Nasdaq: IRWD) was trading 34% lower early ...

Japan’s RaQualia Pharma (TYO: 4579) has announced the termination of the license agreement regarding a retinoic acid receptor ...

A Texan drug compounder cannot rely on federal law to avoid a lawsuit over copycat sales of a rheumatoid arthritis treatment, ...

US pharma giant Pfizer has announced that it is discontinuing development of danuglipron (PF-06882961), an oral glucagon-like ...

The European Commission has approved Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for the ...

The Dutch Healthcare Authority (NZa) has published a report entitled From patent to competition – Analysis of expenditure and ...

Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...

Japanese biotech Prism BioLab has entered a strategic partnership with AI drug discovery company Elix to accelerate the ...

Dutch rare diseases biotech firm ProQR Therapeutics (Nasdaq: PRQR) today announced the appointment of Dr Cristina Lopez Lopez ...

Shares of California-based Coherus BioSciences (Nasdaq: CHRS) rose more than 5% to $0.88 in pre-market activity today as it ...

Belgium’s largest pharma company, has announced findings from a collection of real-world evidence studies to reaffirm the ...

US sequencing firm PacBio (Nasdaq: PACB) is cutting jobs and reducing spending across its business as it braces for the financial impact of new global tariffs and growing uncertainty around federal ...